| |
| |
|
| Insider
Information: |
Manning Anthony M. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
36,693 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$66,781 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,693 |
|
|
| Total
Value |
$66,781 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Palatin Technologies Inc |
PTN |
|
2023-06-20 |
36,693 |
2017-09-07 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Chief Scientific Officer |
2020-10-01 |
0 |
2018-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTN |
Palatin Technologies Inc |
|
– • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
36,693 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
73,000 |
693,667 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
• • – |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
77,000 |
461,666 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,778) |
0 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-08-13 |
4 |
AS |
$29.31 |
$11,813 |
D/D |
(403) |
12,778 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-08-10 |
4 |
AS |
$32.36 |
$11,229 |
D/D |
(347) |
13,181 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
13,528 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-07-21 |
4 |
AS |
$34.67 |
$67,260 |
D/D |
(1,939) |
12,778 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-07-20 |
4 |
OE |
$12.76 |
$422,675 |
D/D |
33,125 |
65,816 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-07-20 |
4 |
AS |
$33.91 |
$1,732,830 |
D/D |
(51,099) |
14,717 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
32,691 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-06-30 |
4 |
AS |
$35.10 |
$239,066 |
D/D |
(6,811) |
29,191 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
36,002 |
0 |
- |
|
| PTN |
Palatin Technologies Inc |
|
• • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
73,000 |
224,583 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-06-12 |
4 |
AS |
$30.15 |
$203,693 |
D/D |
(6,756) |
21,002 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
27,758 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-05-11 |
4 |
AS |
$33.75 |
$13,973 |
D/D |
(414) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-05-08 |
4 |
AS |
$33.30 |
$11,189 |
D/D |
(336) |
13,172 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
13,508 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-04-21 |
4 |
AS |
$30.55 |
$57,617 |
D/D |
(1,886) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-04-20 |
4 |
AS |
$28.96 |
$46,741 |
D/D |
(1,614) |
14,644 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
16,258 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-03-06 |
4 |
AS |
$29.00 |
$211,990 |
D/D |
(7,310) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
20,068 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
AS |
$32.56 |
$535,905 |
D/D |
(16,459) |
5,068 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
